Enhanced shockwave lithotripsy with active cavitation mitigation.


Journal

The Journal of the Acoustical Society of America
ISSN: 1520-8524
Titre abrégé: J Acoust Soc Am
Pays: United States
ID NLM: 7503051

Informations de publication

Date de publication:
11 2019
Historique:
entrez: 5 12 2019
pubmed: 5 12 2019
medline: 12 9 2020
Statut: ppublish

Résumé

The goal of this study was to examine acoustical mechanisms that manipulate cavitation events in order to improve the efficacy of shockwave lithotripsy (SWL) at higher rates. Previous work has shown that applying low amplitude acoustic pulses immediately after each shockwave (SW) can force cavitation bubbles to coalesce and enhance SWL efficacy. In this study, the effects of applying low amplitude acoustic pulses at different time delays is investigated before and after each SW, which would result in different interactions among residual microbubbles producing forced coalescence and dispersion. Utilizing forced coalescence and dispersion was hypothesized to mitigate the shielding effect of residual bubbles, further improving efficacy particularly for higher SWL rates. A set of in vitro experiments was performed in a water tank so that the behavior of bubbles, coalescence and dispersion, could be observed with a high-speed camera. Model kidney stones were treated by a clinical Dornier lithotripter with firing rates of 30 shocks/min and 120 shocks/min, along with an in-house made transducer to generate low amplitude acoustic pulses fired at different pressures and time delays. The average percentage of untreated stone fragments greater than 2 mm was 15.81% for 120 shocks/min without mitigation and significantly reduced to 0.19% for the optimum mitigation protocol.

Identifiants

pubmed: 31795655
doi: 10.1121/1.5131649
pmc: PMC6850953
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3275

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK091267
Pays : United States

Références

J Endourol. 2016 Dec;30(12):1321-1325
pubmed: 27762629
J Endourol. 2006 Aug;20(8):537-41
pubmed: 16903810
IEEE Trans Ultrason Ferroelectr Freq Control. 2013 Feb;60(2):301-9
pubmed: 23357904
IEEE Trans Ultrason Ferroelectr Freq Control. 2015 Dec;62(12):2068-78
pubmed: 26670848
J Mech Behav Biomed Mater. 2010 Jan;3(1):130-3
pubmed: 19878912
J Acoust Soc Am. 2006 Mar;119(3):1432-40
pubmed: 16583887
Ultrasound Med Biol. 2002 May;28(5):661-71
pubmed: 12079703
J Endourol. 2014 Jan;28(1):90-5
pubmed: 23957846
Urology. 1999 Sep;54(3):430-2
pubmed: 10475348
IEEE Trans Ultrason Ferroelectr Freq Control. 2014 Oct;61(10):1619-26
pubmed: 25265172
Urology. 2005 Dec;66(6):1160-4
pubmed: 16360432
J Acoust Soc Am. 1988 Jun;83(6):2190-201
pubmed: 3411016
IEEE Trans Ultrason Ferroelectr Freq Control. 2015 May;62(5):896-904
pubmed: 25965682
Ultrasonics. 2015 Jan;55:65-74
pubmed: 25173067
J Urol. 2005 Aug;174(2):595-9
pubmed: 16006908
Acoust Res Lett Online. 2005 Nov 3;6(4):280-286
pubmed: 19756170
J Urol. 2002 Nov;168(5):2211-5
pubmed: 12394761
Ultrasound Med Biol. 1998 Sep;24(7):1055-9
pubmed: 9809639
J Endourol. 2000 Sep;14(7):547-50
pubmed: 11030533
J Stone Dis. 1992 Jul;4(3):193-207
pubmed: 10147666
J Urol. 1995 Mar;153(3 Pt 1):588-92
pubmed: 7861488
Phys Med Biol. 2000 Jul;45(7):1923-40
pubmed: 10943929
IEEE Trans Ultrason Ferroelectr Freq Control. 2015 Sep;62(9):1605-14
pubmed: 26719861
J Urol. 2005 Jan;173(1):127-30
pubmed: 15592053

Auteurs

Hedieh Alavi Tamaddoni (H)

Department of Biomedical Engineering, University of Michigan, 2131 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, Michigan 48109, USA.

William W Roberts (WW)

Department of Urology, University of Michigan, 4444 Medical Science Building 1, 1301 Catherine Street, Ann Arbor, Michigan 48109, USA.

Timothy L Hall (TL)

Department of Biomedical Engineering, University of Michigan, 2107 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, Michigan 48109, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH